SCHEMBL23749729

SCHEMBL23749729

CNc1cc(-n2ccn(/C(Nc3cc(C)c(F)c(C)c3)=C3\CN(C=O)CCC3=N)c2=O)ccc1P(C)(=O)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24599387 0.70 — —
SCHEMBL25045570 0.64 — —
SCHEMBL23749695 0.59 GLP1R (0.34) —
SCHEMBL25045686 0.57 GLP1R (0.36) —
SCHEMBL23749693 0.56 GLP1R (0.37) —
SCHEMBL25045563 0.54 GLP1R (0.37) —
SCHEMBL22730638 0.46 PDE4D (0.53) —
SCHEMBL524974 0.45 SOS1 (0.39) —
SCHEMBL27254706 0.45 DPP4 (0.36) —
SCHEMBL29177228 0.45 SOS1 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021155841-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. (US) 2021-08-12 — — WO disclosed
Send feedback